Embecta Corp. (EMBC)

NASDAQ: EMBC · Real-Time Price · USD
15.51
-0.99 (-6.00%)
At close: Sep 18, 2024, 4:00 PM
15.50
-0.01 (-0.06%)
After-hours: Sep 18, 2024, 4:09 PM EDT
-6.00%
Market Cap 894.96M
Revenue (ttm) 1.12B
Net Income (ttm) 69.70M
Shares Out 57.70M
EPS (ttm) 1.20
PE Ratio 12.91
Forward PE 7.42
Dividend $0.60 (3.87%)
Ex-Dividend Date Aug 27, 2024
Volume 330,998
Open 16.44
Previous Close 16.50
Day's Range 15.50 - 16.61
52-Week Range 9.93 - 19.79
Beta 0.96
Analysts Sell
Price Target 12.00 (-22.63%)
Earnings Date Aug 9, 2024

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey. [Read more]

Sector Healthcare
Founded 1924
Employees 2,200
Stock Exchange NASDAQ
Ticker Symbol EMBC
Full Company Profile

Financial Performance

In 2023, Embecta's revenue was $1.12 billion, a decrease of -0.77% compared to the previous year's $1.13 billion. Earnings were $70.40 million, a decrease of -68.52%.

Financial Statements

Analyst Forecast

According to one analyst, the rating for EMBC stock is "Sell" and the 12-month stock price forecast is $12.0.

Price Target
$12.0
(-22.63% downside)
Analyst Consensus: Sell
Stock Forecasts

News

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.

15 days ago - GlobeNewsWire

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management...

27 days ago - GlobeNewsWire

Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript

Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Conference Call August 9, 2024 8:00 AM ET Company Participants Pravesh Khandelwal - VP & Head of IR Dev Kurdikar - President, CEO & Director Jake Elguicze...

5 weeks ago - Seeking Alpha

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine m...

5 weeks ago - GlobeNewsWire

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding s...

5 weeks ago - GlobeNewsWire

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector NEW YORK , July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global pr...

Other symbols: G
7 weeks ago - PRNewsWire

embecta to Report Fiscal Third Quarter 2024 Financial Results

PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to ...

2 months ago - GlobeNewsWire

embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the ...

3 months ago - GlobeNewsWire

Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors

WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executi...

3 months ago - PRNewsWire

Embecta (EMBC) CEO on Diabetes Treatment Market

Embecta (EMBC) CEO Dev Kurdikar joins Oliver Renick to give an overview of the company and discuss its 2Q earnings. He also talks about the impact of GLP-1 drugs.

4 months ago - Schwab Network

Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript

Embecta Corp. (NASDAQ:EMBC) Q2 2024 Results Conference Call May 9, 2024 8:00 AM ET Company Participants Pravesh Khandelwal - Vice President & Head of Investor Relations Dev Kurdikar - President, Chie...

4 months ago - Seeking Alpha

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six mon...

4 months ago - GlobeNewsWire

embecta to Report Fiscal Second Quarter 2024 Financial Results

PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to...

5 months ago - GlobeNewsWire

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorshi...

7 months ago - GlobeNewsWire

Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript

Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript

7 months ago - Seeking Alpha

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month peri...

7 months ago - GlobeNewsWire

embecta to Participate in the 11th Annual BTIG MedTech Conference

PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at the ...

8 months ago - GlobeNewsWire

embecta to Report Fiscal First Quarter 2024 Financial Results

PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to ...

8 months ago - GlobeNewsWire

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that it has sub...

9 months ago - GlobeNewsWire

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wed...

9 months ago - GlobeNewsWire

No embecta-made syringes impacted by FDA safety communication

PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug Admi...

10 months ago - GlobeNewsWire

embecta to Participate in Investor Conferences

PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following investor...

10 months ago - GlobeNewsWire

Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript

Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

PARSIPPANY, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelv...

10 months ago - GlobeNewsWire

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

embecta (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq opening bell in recognition of National Diabetes Awareness Month.

11 months ago - GlobeNewsWire